Unraveling the Uncommon: A Case Report of Giant Cell Myocarditis and Examination of Existing Literature
American Journal of Case Reports · 2024
DOI: 10.12659/ajcr.942381 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2024. Verfasst von Yurilu A Gonzalez Moret und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Jefferson Einstein Hospital, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Myocarditis, Heart Failure, Heart Transplantation. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Idiopathic giant cell myocarditis (IGCM) is an uncommon and frequently fatal type of myocarditis. It primarily affects young individuals and has the potential to result in heart failure and life-threatening arrhythmias. IGCM seems to be dependent on activation of CD4-positive T lymphocytes and can show improvement with treatment aimed at reducing T-cell function. We present a case of a 65-year-old patient who presented with features of acute heart failure refractory to guideline-directed medical therapy (GDMT), due to IGCM. A review of the natural history and treatment of IGCM is also presented. CASE REPORT A 65-year-old woman with multiple comorbidities was admitted to our hospital for ventricular tachycardia in the setting of progressive non-ischemic heart failure, unresponsive to GDMT. This led to further investigation, including an endomyocardial biopsy, which revealed inflammatory infiltration, with multinucleated giant cells and lymphocytes in the absence of granuloma formation, prompting a diagnosis of IGCM. An implantable cardioverter-defibrillator (ICD) was placed for secondary prevention of sudden cardiac death and the patient was initiated on combined immunosuppressive therapy. Owing to numerous comorbidities, she was determined to be unsuitable for a heart transplant. Unfortunately, she eventually died from complications secondary to the disease. CONCLUSIONS IGCM remains a challenging clinical diagnosis with a poor long-term outcome without heart transplantation. This case highlights the importance of considering atypical causes of heart failure in patients who do not respond to conventional therapies. Early recognition and appropriate management, involving medical and interventional approaches, are crucial in improving outcomes for patients with IGCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, Jefferson Einstein Hospital, Philadelphia, PA, USA.
- Sidney Kimmel College of Medicine of Thomas Jefferson University, Philadelphia, PA, USA.
- Department of Cardiology, Jefferson Einstein Hospital, Philadelphia, PA, USA.
- Department of Pathology-Hematology, Jefferson Einstein Hospital, Philadelphia, PA, USA.
ORCID-Profile: Yurilu A Gonzalez Moret, Simone A Jarrett, Rekha R Bhat
Zitieren
APA
Gonzalez Moret, Y. A., Jarrett, S. A., Ahktar, H., Moghbeli, N., Hasni, S., Bozorgnia, B., & Bhat, R. R. (2024). Unraveling the Uncommon: A Case Report of Giant Cell Myocarditis and Examination of Existing Literature. American Journal of Case Reports. https://doi.org/10.12659/ajcr.942381
Vancouver
Gonzalez Moret YA, Jarrett SA, Ahktar H, Moghbeli N, Hasni S, Bozorgnia B, et al. Unraveling the Uncommon: A Case Report of Giant Cell Myocarditis and Examination of Existing Literature. American Journal of Case Reports. 2024. doi:10.12659/ajcr.942381
BibTeX
@article{GonzalezMoret2024,
author = {Gonzalez Moret, Yurilu A and Jarrett, Simone A and Ahktar, Hamza and Moghbeli, Nazanin and Hasni, Syed and Bozorgnia, Behnam and Bhat, Rekha R},
title = {Unraveling the Uncommon: A Case Report of Giant Cell Myocarditis and Examination of Existing Literature},
journal = {American Journal of Case Reports},
year = {2024},
doi = {10.12659/ajcr.942381}
}
EUVIMED